Department of Respiratory Sciences, 574216University of Leicester, Leicester, UK.
Centre for Exercise and Rehabilitation Science, NIHR Leicester Biomedical Research Centre-Respiratory, 4490University Hospitals of Leicester NHS Trust, Leicester, UK.
Chron Respir Dis. 2022 Jan-Dec;19:14799731221129286. doi: 10.1177/14799731221129286.
During pulmonary rehabilitation (PR), patients receive individually tailored walking exercise training. The personalised nature of exercise prescription is a fundamental component of PR. Despite this, the measurement of physical activity (PA) has been limited to a 'one size fits all' approach and can be challenging to translate into clinically meaningful or real-world units, such as cadence. This discrepancy may partly explain the inconsistent evidence for the impact of PR on PA. It may also provide an opportunity to standardise PA assessment in the context of chronic respiratory disease (CRD) and PR, where field-based walking tests are routine measures. This technical note provides an example of how to develop personalised PA intensity thresholds, calibrated against an individual's performance on the Incremental Shuttle Walking Test (ISWT; maximal) and Endurance Shuttle Walk Test (ESWT; sub-maximal). These are externally paced tests, with each level (speed) of the tests denoting a specific speed (intensity); ranging 1.8 km/h (ISWT Level 1) to 8.5 km/h (ISWT Level 12). From the ESWT, it becomes possible to evaluate adherence to each individual's walking exercise prescription. Future research should explore this approach and its responsiveness to PR. It may be possible to extend this methodology with the inclusion of physiological parameters (e.g., heart rate, calorimetry, and oxygen consumption) to derive relative intensity markers (e.g. moderate-to-vigorous), accounting for individual differences in exercise capacity, under the same paradigm as PR exercise prescription.
在肺康复 (PR) 期间,患者接受个体化量身定制的步行运动训练。运动处方的个性化是 PR 的一个基本组成部分。尽管如此,身体活动 (PA) 的测量一直局限于“一刀切”的方法,并且难以转化为具有临床意义或现实世界的单位,例如步频。这种差异可能部分解释了 PR 对 PA 的影响证据不一致的原因。它也可能为在慢性呼吸系统疾病 (CRD) 和 PR 的背景下标准化 PA 评估提供机会,在这些情况下,基于现场的步行测试是常规措施。本技术说明提供了一个示例,说明如何针对个体在递增穿梭步行测试 (ISWT;最大) 和耐力穿梭步行测试 (ESWT;次最大) 上的表现,针对个人开发个性化 PA 强度阈值。这些是外部定速测试,每个测试级别 (速度) 都表示特定的速度 (强度);范围为 1.8 公里/小时 (ISWT 级别 1) 到 8.5 公里/小时 (ISWT 级别 12)。从 ESWT 中,可以评估对每个人的步行运动处方的遵守情况。未来的研究应探索这种方法及其对 PR 的反应性。随着纳入生理参数(例如心率、热量测定和耗氧量),有可能扩展这种方法,以根据 PR 运动处方的相同范式,为每个个体的运动能力差异得出相对强度标志物(例如适度到剧烈)。